Evidence map›Paper›PMID 39950457›Full record

ReviewCurrent pharmaceutical design2025

Recent Advances in Cationic Nanoemulsions for Drug Delivery: Preparation, Properties, and Applications.

Huanfan He, Jiayu Li, Hong Meng, Yifan He, Xiaojing Pei, Ze Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huanfan HeInstitute of Regulatory Science, School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing, China.
Jiayu LiInstitute of Regulatory Science, School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing, China.
Hong MengInstitute of Regulatory Science, School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing, China.
Yifan HeInstitute of Regulatory Science, School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing, China.
Xiaojing PeiInstitute of Regulatory Science, School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing, China.
Ze ZhangLight Industry and Food Experimental Teaching Center, Beijing Technology and Business University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoemulsions have gained popularity as drug delivery vehicles owing to the enhanced solubility of insoluble drugs, the augmented stability of photo- and thermosensitive substances, and the facilitation of transdermal permeation of efficacy substances. As the cell surfaces of the skin, cornea, gastrointestinal mucosa, and other cells in living organisms carry negative charges, cationic nanoemulsions (CNE) mainly promote drug absorption through electrostatic effects. In this review, a brief characterization of CNEs is provided, and the types of cationic agents and their roles in nanoemulsions, including cationic surfactants, cationic lipids, cationic polymers, cationized polysaccharides, and phytosphingosine (PS), are discussed. In addition, the current application circumstances of CNEs in ocular drug delivery, mucosal drug delivery, and transdermal drug delivery systems are elaborated on, and the crucial matters that require attention during the research process are briefly discussed. Eventually, the extensive application prospects of CNEs are envisioned.

Indexed as

Drug Delivery SystemsNanoparticlesAnimalsCationsEmulsionsHumansCationsEmulsionscationic agentsCationic nanoemulsionscationic surfactants.drug delivery systemselectrostatic interactionpolyelectrolytes

Identifiers

PMID39950457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.